Hrt Financial LP Chembio Diagnostics, Inc. Transaction History

Hrt Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.25 - $0.45 $24,108 - $43,395	96,434 New	96,434 $42,000
Q3 2022 Nov 14, 2022	BUY	$0.35 - $1.1 $11,712 - $36,809	33,463 New	33,463 $12,000
Q1 2022 May 16, 2022	SELL	$0.66 - $1.23 $12,511 - $23,317	-18,957 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.09 - $2.55 $20,663 - $48,340	18,957 New	18,957 $21,000
Q3 2021 Nov 15, 2021	SELL	$2.06 - $5.34 $116,334 - $301,565	-56,473 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.88 - $5.64 $162,642 - $318,507	56,473 New	56,473 $167,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.